nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—ACY1—thyroid gland—thyroid cancer	0.0152	0.0898	CbGeAlD
Acetylcysteine—Haemoptysis—Vandetanib—thyroid cancer	0.0145	0.0444	CcSEcCtD
Acetylcysteine—ACY1—head—thyroid cancer	0.0135	0.0796	CbGeAlD
Acetylcysteine—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.0123	0.0377	CcSEcCtD
Acetylcysteine—GSS—saliva-secreting gland—thyroid cancer	0.0115	0.0677	CbGeAlD
Acetylcysteine—Respiratory distress—Sorafenib—thyroid cancer	0.0114	0.0349	CcSEcCtD
Acetylcysteine—CHUK—thyroid gland—thyroid cancer	0.0105	0.062	CbGeAlD
Acetylcysteine—GRIN2D—head—thyroid cancer	0.00957	0.0564	CbGeAlD
Acetylcysteine—CHUK—head—thyroid cancer	0.00933	0.055	CbGeAlD
Acetylcysteine—GRIN3A—head—thyroid cancer	0.009	0.053	CbGeAlD
Acetylcysteine—Rhinorrhoea—Sorafenib—thyroid cancer	0.00893	0.0274	CcSEcCtD
Acetylcysteine—GSS—trachea—thyroid cancer	0.00887	0.0523	CbGeAlD
Acetylcysteine—SLC7A11—thyroid gland—thyroid cancer	0.00866	0.051	CbGeAlD
Acetylcysteine—GRIN1—head—thyroid cancer	0.00853	0.0503	CbGeAlD
Acetylcysteine—GRIN2B—head—thyroid cancer	0.00814	0.048	CbGeAlD
Acetylcysteine—SLC7A11—head—thyroid cancer	0.00768	0.0453	CbGeAlD
Acetylcysteine—Sensitisation—Epirubicin—thyroid cancer	0.00748	0.0229	CcSEcCtD
Acetylcysteine—IKBKB—thyroid gland—thyroid cancer	0.00715	0.0421	CbGeAlD
Acetylcysteine—GRIN2A—head—thyroid cancer	0.00711	0.0419	CbGeAlD
Acetylcysteine—GSS—thyroid gland—thyroid cancer	0.00702	0.0413	CbGeAlD
Acetylcysteine—Nasopharyngitis—Vandetanib—thyroid cancer	0.00696	0.0213	CcSEcCtD
Acetylcysteine—Sensitisation—Doxorubicin—thyroid cancer	0.00692	0.0212	CcSEcCtD
Acetylcysteine—Bronchospasm—Vandetanib—thyroid cancer	0.00662	0.0203	CcSEcCtD
Acetylcysteine—CHUK—lymph node—thyroid cancer	0.00653	0.0385	CbGeAlD
Acetylcysteine—IKBKB—head—thyroid cancer	0.00634	0.0374	CbGeAlD
Acetylcysteine—GSS—head—thyroid cancer	0.00622	0.0367	CbGeAlD
Acetylcysteine—Stomatitis—Vandetanib—thyroid cancer	0.00585	0.0179	CcSEcCtD
Acetylcysteine—Cardiac disorder—Vandetanib—thyroid cancer	0.005	0.0153	CcSEcCtD
Acetylcysteine—Angiopathy—Vandetanib—thyroid cancer	0.00488	0.015	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vandetanib—thyroid cancer	0.00485	0.0149	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00469	0.0144	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—thyroid cancer	0.00444	0.0262	CbGeAlD
Acetylcysteine—GSS—lymph node—thyroid cancer	0.00436	0.0257	CbGeAlD
Acetylcysteine—Loss of consciousness—Vandetanib—thyroid cancer	0.00412	0.0126	CcSEcCtD
Acetylcysteine—Cough—Vandetanib—thyroid cancer	0.00409	0.0125	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00396	0.0121	CcSEcCtD
Acetylcysteine—Stomatitis—Sorafenib—thyroid cancer	0.00394	0.0121	CcSEcCtD
Acetylcysteine—Oedema—Vandetanib—thyroid cancer	0.00382	0.0117	CcSEcCtD
Acetylcysteine—Skin disorder—Vandetanib—thyroid cancer	0.00371	0.0114	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—thyroid cancer	0.00361	0.0111	CcSEcCtD
Acetylcysteine—Dyspnoea—Vandetanib—thyroid cancer	0.00341	0.0105	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—thyroid cancer	0.0034	0.0104	CcSEcCtD
Acetylcysteine—Flushing—Sorafenib—thyroid cancer	0.00337	0.0103	CcSEcCtD
Acetylcysteine—Cardiac disorder—Sorafenib—thyroid cancer	0.00337	0.0103	CcSEcCtD
Acetylcysteine—Dyspepsia—Vandetanib—thyroid cancer	0.00337	0.0103	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—thyroid cancer	0.00334	0.0102	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0033	0.0101	CcSEcCtD
Acetylcysteine—Angiopathy—Sorafenib—thyroid cancer	0.00329	0.0101	CcSEcCtD
Acetylcysteine—Immune system disorder—Sorafenib—thyroid cancer	0.00328	0.0101	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00327	0.01	CcSEcCtD
Acetylcysteine—Erythema—Sorafenib—thyroid cancer	0.00316	0.00969	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—thyroid cancer	0.00315	0.00966	CcSEcCtD
Acetylcysteine—Body temperature increased—Vandetanib—thyroid cancer	0.00302	0.00927	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—thyroid cancer	0.00292	0.00895	CcSEcCtD
Acetylcysteine—Angioedema—Sorafenib—thyroid cancer	0.00289	0.00885	CcSEcCtD
Acetylcysteine—Syncope—Sorafenib—thyroid cancer	0.00283	0.00869	CcSEcCtD
Acetylcysteine—Loss of consciousness—Sorafenib—thyroid cancer	0.00278	0.00852	CcSEcCtD
Acetylcysteine—Cough—Sorafenib—thyroid cancer	0.00276	0.00846	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—thyroid cancer	0.00274	0.00839	CcSEcCtD
Acetylcysteine—Pruritus—Vandetanib—thyroid cancer	0.00271	0.00829	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—thyroid cancer	0.0027	0.00828	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00267	0.00819	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00258	0.00791	CcSEcCtD
Acetylcysteine—Shock—Sorafenib—thyroid cancer	0.00254	0.00778	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—thyroid cancer	0.00253	0.00777	CcSEcCtD
Acetylcysteine—Dizziness—Vandetanib—thyroid cancer	0.00253	0.00775	CcSEcCtD
Acetylcysteine—Skin disorder—Sorafenib—thyroid cancer	0.00251	0.00768	CcSEcCtD
Acetylcysteine—Vomiting—Vandetanib—thyroid cancer	0.00243	0.00745	CcSEcCtD
Acetylcysteine—Rash—Vandetanib—thyroid cancer	0.00241	0.00739	CcSEcCtD
Acetylcysteine—Dermatitis—Vandetanib—thyroid cancer	0.00241	0.00739	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—thyroid cancer	0.00232	0.00711	CcSEcCtD
Acetylcysteine—Dyspnoea—Sorafenib—thyroid cancer	0.0023	0.00705	CcSEcCtD
Acetylcysteine—Nausea—Vandetanib—thyroid cancer	0.00227	0.00696	CcSEcCtD
Acetylcysteine—Dyspepsia—Sorafenib—thyroid cancer	0.00227	0.00696	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00223	0.00683	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—thyroid cancer	0.00215	0.00659	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—thyroid cancer	0.00215	0.00658	CcSEcCtD
Acetylcysteine—Urticaria—Sorafenib—thyroid cancer	0.00205	0.00628	CcSEcCtD
Acetylcysteine—Body temperature increased—Sorafenib—thyroid cancer	0.00204	0.00625	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.002	0.00614	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—thyroid cancer	0.00199	0.00609	CcSEcCtD
Acetylcysteine—Hypersensitivity—Sorafenib—thyroid cancer	0.0019	0.00583	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—thyroid cancer	0.00187	0.00574	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00185	0.00568	CcSEcCtD
Acetylcysteine—Pruritus—Sorafenib—thyroid cancer	0.00183	0.0056	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00173	0.00532	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—thyroid cancer	0.00173	0.00531	CcSEcCtD
Acetylcysteine—Dizziness—Sorafenib—thyroid cancer	0.00171	0.00523	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—thyroid cancer	0.00168	0.00514	CcSEcCtD
Acetylcysteine—Vomiting—Sorafenib—thyroid cancer	0.00164	0.00503	CcSEcCtD
Acetylcysteine—Rash—Sorafenib—thyroid cancer	0.00163	0.00499	CcSEcCtD
Acetylcysteine—Dermatitis—Sorafenib—thyroid cancer	0.00163	0.00498	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00161	0.00492	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—thyroid cancer	0.00155	0.00476	CcSEcCtD
Acetylcysteine—Nausea—Sorafenib—thyroid cancer	0.00153	0.0047	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—thyroid cancer	0.00149	0.00458	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—thyroid cancer	0.00146	0.00447	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—thyroid cancer	0.00143	0.00439	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—thyroid cancer	0.00138	0.00424	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—thyroid cancer	0.00135	0.00413	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—thyroid cancer	0.00133	0.00408	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—thyroid cancer	0.00133	0.00407	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—thyroid cancer	0.00125	0.00382	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—thyroid cancer	0.00125	0.00382	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—thyroid cancer	0.00123	0.00378	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—thyroid cancer	0.00122	0.00373	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—thyroid cancer	0.00121	0.00372	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00121	0.00371	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—thyroid cancer	0.00117	0.00358	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—thyroid cancer	0.00115	0.00353	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—thyroid cancer	0.00115	0.00353	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—thyroid cancer	0.00113	0.00345	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—thyroid cancer	0.00112	0.00344	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00112	0.00343	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—thyroid cancer	0.00108	0.00331	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—thyroid cancer	0.00105	0.00321	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—thyroid cancer	0.00103	0.00315	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—thyroid cancer	0.00102	0.00312	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000988	0.00303	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—thyroid cancer	0.000969	0.00297	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—thyroid cancer	0.000953	0.00292	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000953	0.00292	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00095	0.00291	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—thyroid cancer	0.000943	0.00289	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—thyroid cancer	0.000938	0.00288	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—thyroid cancer	0.000931	0.00285	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—thyroid cancer	0.000926	0.00284	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000922	0.00283	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000914	0.0028	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—thyroid cancer	0.000891	0.00273	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—thyroid cancer	0.000882	0.0027	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000882	0.0027	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—thyroid cancer	0.000868	0.00266	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—thyroid cancer	0.000861	0.00264	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—thyroid cancer	0.000857	0.00263	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000853	0.00261	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—thyroid cancer	0.00085	0.00261	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—thyroid cancer	0.000848	0.0026	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—thyroid cancer	0.000839	0.00257	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—thyroid cancer	0.000824	0.00253	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000823	0.00252	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—thyroid cancer	0.000787	0.00241	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—thyroid cancer	0.000784	0.0024	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—thyroid cancer	0.000777	0.00238	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000762	0.00233	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—thyroid cancer	0.000757	0.00232	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—thyroid cancer	0.000754	0.00231	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—thyroid cancer	0.000702	0.00215	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—thyroid cancer	0.000701	0.00215	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—thyroid cancer	0.000697	0.00214	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—thyroid cancer	0.000675	0.00207	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00065	0.00199	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—thyroid cancer	0.00063	0.00193	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—thyroid cancer	0.000624	0.00191	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—thyroid cancer	0.000606	0.00186	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—thyroid cancer	0.000601	0.00184	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—thyroid cancer	0.000601	0.00184	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—thyroid cancer	0.000583	0.00179	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—thyroid cancer	0.000566	0.00174	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—thyroid cancer	0.000561	0.00172	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—thyroid cancer	0.000556	0.00171	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—thyroid cancer	0.000556	0.0017	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—thyroid cancer	0.000524	0.00161	CcSEcCtD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000324	0.000642	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KRAS—thyroid cancer	0.000323	0.000641	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—HRAS—thyroid cancer	0.000322	0.00064	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—BRAF—thyroid cancer	0.000322	0.000638	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—NRAS—thyroid cancer	0.000322	0.000638	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDK1—thyroid cancer	0.000322	0.000638	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thyroid cancer	0.000321	0.000637	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000321	0.000637	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—NRAS—thyroid cancer	0.00032	0.000635	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.00032	0.000635	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—KRAS—thyroid cancer	0.000318	0.000631	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000316	0.000627	CbGpPWpGaD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000313	0.000621	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—thyroid cancer	0.000311	0.000617	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—thyroid cancer	0.00031	0.000615	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—NRAS—thyroid cancer	0.000309	0.000614	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IFNA2—thyroid cancer	0.000309	0.000613	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PTEN—thyroid cancer	0.000308	0.000611	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—PTEN—thyroid cancer	0.000308	0.000611	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TPR—thyroid cancer	0.000305	0.000605	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—KRAS—thyroid cancer	0.000304	0.000603	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—NRAS—thyroid cancer	0.000303	0.000601	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—NRAS—thyroid cancer	0.000303	0.000601	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—KRAS—thyroid cancer	0.000302	0.0006	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—LGALS3—thyroid cancer	0.000302	0.0006	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—KRAS—thyroid cancer	0.000301	0.000597	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PRKAR1A—thyroid cancer	0.0003	0.000595	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—KRAS—thyroid cancer	0.000299	0.000594	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—NRAS—thyroid cancer	0.000298	0.000592	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000298	0.000591	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—thyroid cancer	0.000297	0.000589	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000295	0.000586	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000292	0.000579	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—NRAS—thyroid cancer	0.000291	0.000577	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.00029	0.000575	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000287	0.00057	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRG1—thyroid cancer	0.000285	0.000565	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000284	0.000564	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—HRAS—thyroid cancer	0.000282	0.00056	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—HRAS—thyroid cancer	0.000282	0.00056	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—KRAS—thyroid cancer	0.000282	0.000559	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000282	0.000559	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000282	0.000559	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TPR—thyroid cancer	0.000281	0.000558	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—KRAS—thyroid cancer	0.000279	0.000554	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000279	0.000554	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PRKAR1A—thyroid cancer	0.000277	0.000549	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000277	0.000549	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TPR—thyroid cancer	0.000276	0.000548	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—KRAS—thyroid cancer	0.000276	0.000547	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000275	0.000545	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—NRAS—thyroid cancer	0.000275	0.000545	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—LGALS3—thyroid cancer	0.000274	0.000544	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRG1—thyroid cancer	0.000273	0.000542	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PRKAR1A—thyroid cancer	0.000272	0.000539	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—thyroid cancer	0.000271	0.000537	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TCF7L1—thyroid cancer	0.000269	0.000534	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000268	0.000531	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000266	0.000528	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000265	0.000527	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000265	0.000526	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MEN1—thyroid cancer	0.000265	0.000525	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KRAS—thyroid cancer	0.000261	0.000517	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—KRAS—thyroid cancer	0.000261	0.000517	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—thyroid cancer	0.000258	0.000513	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRG1—thyroid cancer	0.000258	0.000512	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PPARG—thyroid cancer	0.000258	0.000512	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—thyroid cancer	0.000257	0.00051	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—KRAS—thyroid cancer	0.000257	0.000509	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000257	0.000509	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—thyroid cancer	0.000256	0.000508	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—thyroid cancer	0.000256	0.000507	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000255	0.000507	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—thyroid cancer	0.000255	0.000505	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000254	0.000503	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000251	0.000498	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KRAS—thyroid cancer	0.00025	0.000497	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PTEN—thyroid cancer	0.00025	0.000496	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.00025	0.000495	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—AKT1—thyroid cancer	0.000249	0.000495	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRG1—thyroid cancer	0.000248	0.000492	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—thyroid cancer	0.000246	0.000488	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TCF7L1—thyroid cancer	0.000244	0.000484	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.000243	0.000481	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.00024	0.000476	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—thyroid cancer	0.00024	0.000476	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—thyroid cancer	0.000239	0.000475	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000239	0.000475	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000239	0.000475	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—AKT1—thyroid cancer	0.000239	0.000474	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—thyroid cancer	0.000237	0.000471	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—thyroid cancer	0.000237	0.00047	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—thyroid cancer	0.000236	0.000469	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000236	0.000467	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—thyroid cancer	0.000235	0.000467	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000235	0.000467	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—thyroid cancer	0.000234	0.000465	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000233	0.000462	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—thyroid cancer	0.000232	0.00046	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—AKT1—thyroid cancer	0.000228	0.000453	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000227	0.000451	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—AKT1—thyroid cancer	0.000227	0.00045	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—thyroid cancer	0.000227	0.00045	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PTEN—thyroid cancer	0.000227	0.00045	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—AKT1—thyroid cancer	0.000226	0.000449	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—AKT1—thyroid cancer	0.000226	0.000448	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—AKT1—thyroid cancer	0.000225	0.000446	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—thyroid cancer	0.000223	0.000442	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—thyroid cancer	0.000222	0.00044	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—thyroid cancer	0.000222	0.00044	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.000222	0.000439	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—thyroid cancer	0.000218	0.000433	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000217	0.000431	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—thyroid cancer	0.000213	0.000422	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—thyroid cancer	0.000213	0.000422	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000212	0.000421	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000211	0.000419	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000211	0.000419	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—AKT1—thyroid cancer	0.000211	0.000419	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CALCA—thyroid cancer	0.000211	0.000418	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—AKT1—thyroid cancer	0.00021	0.000416	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—AKT1—thyroid cancer	0.000208	0.000412	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000208	0.000412	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—thyroid cancer	0.000208	0.000412	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—thyroid cancer	0.000207	0.00041	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDK1—thyroid cancer	0.000207	0.00041	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—thyroid cancer	0.000206	0.000408	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—thyroid cancer	0.000203	0.000403	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—thyroid cancer	0.000202	0.000401	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—thyroid cancer	0.000201	0.000399	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.000201	0.000398	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—thyroid cancer	0.0002	0.000397	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000199	0.000395	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNA2—thyroid cancer	0.000199	0.000394	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TPR—thyroid cancer	0.000198	0.000392	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSHR—thyroid cancer	0.000197	0.000391	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—thyroid cancer	0.000196	0.000388	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—thyroid cancer	0.000196	0.000388	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.000195	0.000387	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	0.000194	0.000386	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKAR1A—thyroid cancer	0.000194	0.000385	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—thyroid cancer	0.000192	0.000381	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000192	0.00038	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDK1—thyroid cancer	0.000191	0.000378	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000187	0.000372	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDK1—thyroid cancer	0.000187	0.000372	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MEN1—thyroid cancer	0.000185	0.000368	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—thyroid cancer	0.000183	0.000364	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNA2—thyroid cancer	0.00018	0.000357	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSHR—thyroid cancer	0.000179	0.000354	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—thyroid cancer	0.000179	0.000354	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—thyroid cancer	0.000178	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—thyroid cancer	0.000177	0.000352	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—thyroid cancer	0.000177	0.000351	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.000177	0.000351	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000176	0.00035	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKAR1A—thyroid cancer	0.000176	0.000349	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—thyroid cancer	0.000174	0.000345	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MEN1—thyroid cancer	0.000168	0.000333	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTCH1—thyroid cancer	0.000168	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.000166	0.000329	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRG1—thyroid cancer	0.000166	0.000329	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—thyroid cancer	0.000163	0.000324	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—thyroid cancer	0.000156	0.000309	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SST—thyroid cancer	0.000153	0.000304	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRG1—thyroid cancer	0.000153	0.000304	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTCH1—thyroid cancer	0.000152	0.000301	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—thyroid cancer	0.000152	0.000301	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.00015	0.000298	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRG1—thyroid cancer	0.00015	0.000298	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	0.000148	0.000294	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—thyroid cancer	0.000148	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CALCA—thyroid cancer	0.000148	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—thyroid cancer	0.000144	0.000286	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—thyroid cancer	0.000143	0.000283	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SST—thyroid cancer	0.000139	0.000276	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000139	0.000275	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—thyroid cancer	0.000138	0.000273	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—thyroid cancer	0.000137	0.000273	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—thyroid cancer	0.000137	0.000272	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—thyroid cancer	0.000134	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CALCA—thyroid cancer	0.000134	0.000265	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDK1—thyroid cancer	0.000134	0.000265	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HIF1A—thyroid cancer	0.000131	0.000261	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—thyroid cancer	0.000131	0.000259	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—thyroid cancer	0.000129	0.000256	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—thyroid cancer	0.000127	0.000252	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—RXRA—thyroid cancer	0.000124	0.000247	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—thyroid cancer	0.000124	0.000246	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—thyroid cancer	0.000122	0.000242	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDK1—thyroid cancer	0.000121	0.00024	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000121	0.00024	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—thyroid cancer	0.000115	0.000229	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—thyroid cancer	0.000111	0.00022	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—thyroid cancer	0.000109	0.000217	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—thyroid cancer	0.000109	0.000216	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRG1—thyroid cancer	0.000107	0.000213	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—thyroid cancer	0.000105	0.000209	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—thyroid cancer	0.000102	0.000202	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—thyroid cancer	9.93e-05	0.000197	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRG1—thyroid cancer	9.72e-05	0.000193	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—thyroid cancer	9.62e-05	0.000191	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—thyroid cancer	9.53e-05	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—thyroid cancer	9.3e-05	0.000185	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—thyroid cancer	9.2e-05	0.000183	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—thyroid cancer	8.94e-05	0.000177	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—thyroid cancer	8.79e-05	0.000174	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—thyroid cancer	8.73e-05	0.000173	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—thyroid cancer	8.44e-05	0.000167	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—thyroid cancer	8.35e-05	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—thyroid cancer	8.3e-05	0.000165	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—thyroid cancer	8.22e-05	0.000163	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—thyroid cancer	8.1e-05	0.000161	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—thyroid cancer	7.89e-05	0.000157	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—thyroid cancer	7.85e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—thyroid cancer	7.67e-05	0.000152	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—thyroid cancer	7.62e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—thyroid cancer	7.53e-05	0.000149	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—thyroid cancer	7.45e-05	0.000148	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—thyroid cancer	7.41e-05	0.000147	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—thyroid cancer	7.15e-05	0.000142	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—thyroid cancer	6.91e-05	0.000137	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—thyroid cancer	6.84e-05	0.000136	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—thyroid cancer	6.72e-05	0.000133	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—thyroid cancer	6.38e-05	0.000126	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—thyroid cancer	6.17e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—thyroid cancer	5.89e-05	0.000117	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—thyroid cancer	5.78e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—thyroid cancer	5.56e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—thyroid cancer	5.42e-05	0.000108	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—thyroid cancer	5.39e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—thyroid cancer	5.37e-05	0.000107	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—thyroid cancer	5.04e-05	0.0001	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—thyroid cancer	5e-05	9.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—thyroid cancer	4.91e-05	9.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—thyroid cancer	4.87e-05	9.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—thyroid cancer	4.79e-05	9.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—thyroid cancer	4.79e-05	9.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—thyroid cancer	4.42e-05	8.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—thyroid cancer	4.34e-05	8.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—thyroid cancer	4.34e-05	8.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—thyroid cancer	4.12e-05	8.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—thyroid cancer	3.74e-05	7.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—thyroid cancer	3.66e-05	7.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—thyroid cancer	3.5e-05	6.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—thyroid cancer	3.32e-05	6.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—thyroid cancer	3.18e-05	6.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—thyroid cancer	3.1e-05	6.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—thyroid cancer	3.09e-05	6.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—thyroid cancer	2.81e-05	5.57e-05	CbGpPWpGaD
